{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:39:02Z","timestamp":1791272342212,"version":"4.1.0"},"reference-count":55,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1548,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1365-2184.2011.00761.x","type":"journal-article","created":{"date-parts":[[2011,6,6]],"date-time":"2011-06-06T12:11:05Z","timestamp":1307362265000},"page":"320-329","source":"Crossref","is-referenced-by-count":36,"title":["Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G2\/M phase arrest"],"prefix":"10.1111","volume":"44","author":[{"given":"Y.-S.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-M.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-H.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-Y.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-M.","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-W.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-T.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-P.","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-S.","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,6]]},"reference":[{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11864-001-0033-5","article-title":"Metastatic melanoma","volume":"2","author":"Sun","year":"2001","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ijc.1378","article-title":"Drug-resistance in human melanoma","volume":"93","author":"Helmbach","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35051606","article-title":"Inactivation of the apoptosis effector Apaf-1 in malignant melanoma","volume":"409","author":"Soengas","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/1097-0142(19941101)74:9<2476::AID-CNCR2820740914>3.0.CO;2-Z","article-title":"Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma","volume":"74","author":"Buzaid","year":"1994","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature05661","article-title":"Melanoma biology and new targeted therapy","volume":"445","author":"Gray-Schopfer","year":"2007","journal-title":"Nature"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2331s","DOI":"10.1158\/1078-0432.CCR-05-2538","article-title":"Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations","volume":"12","author":"Kirkwood","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<89::AID-CNCR15>3.0.CO;2-4","article-title":"Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma","volume":"77","author":"Legha","year":"1996","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7164\/antibiotics.25.109","article-title":"Myriocin, a new antifungal antibiotic from Myriococcum albomyces","volume":"25","author":"Kluepfel","year":"1972","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/jo00947a001","article-title":"Elucidation of structure and stereochemistry of myriocin. A novel antifungal antibiotics","volume":"38","author":"St-Jacques","year":"1973","journal-title":"J. Org. Chem."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1248\/cpb.42.2662","article-title":"Synthesis of new immunosuppressive myriocin analogs, 2-epi-myriocin, 14-deoxomyriocin, Z-14-deoxomyriocin, and nor-deoxomyriocins: their structure-activity relationships","volume":"42","author":"Yoshikawa","year":"1994","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1006\/bbrc.1995.1827","article-title":"Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1\/myriocin","volume":"211","author":"Miyake","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.1074\/jbc.M412348200","article-title":"Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice","volume":"280","author":"Hojjati","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bcp.2006.12.023","article-title":"Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration","volume":"73","author":"Glaros","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.embor.7400208","article-title":"The complex life of simple sphingolipids","volume":"5","author":"Futerman","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"11320","DOI":"10.1074\/jbc.M309262200","article-title":"Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2","volume":"279","author":"Pettus","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/1535-7163.MCT-05-0420","article-title":"Sphingolipid targets in cancer therapy","volume":"5","author":"Modrak","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc1411","article-title":"Biologically active sphingolipids in cancer pathogenesis and treatment","volume":"4","author":"Ogretmen","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/1389450043345452","article-title":"Sphingolipid metabolism enzymes as targets for anticancer therapy","volume":"5","author":"Kok","year":"2004","journal-title":"Curr. Drug Targets"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.8456305","article-title":"Programmed cell death induced by ceramide","volume":"259","author":"Obeid","year":"1993","journal-title":"Science"},{"issue":"Suppl.","key":"10.1111\/j.1365-2184.2011.00761.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/BF02562235","article-title":"Role of sphingosine in induced apoptosis","volume":"34","author":"Alessenko","year":"1999","journal-title":"Lipids"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/365557a0","article-title":"Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens","volume":"365","author":"Olivera","year":"1993","journal-title":"Nature"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1096\/fj.01-0863fje","article-title":"Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus","volume":"16","author":"Veldman","year":"2002","journal-title":"FASEB J."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/sj.onc.1207542","article-title":"Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression","volume":"23","author":"Fingar","year":"2004","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.onc.1204252","article-title":"Regulation of the G2\/M transition by p53","volume":"20","author":"Taylor","year":"2001","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0092-8674(89)90936-7","article-title":"Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2","volume":"58","author":"Pines","year":"1989","journal-title":"Cell"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1200\/JCO.2005.18.341","article-title":"Development of cell cycle active drugs for the treatment of gastrointestinal cancers: a new approach to cancer therapy","volume":"23","author":"Schwartz","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB28|cit28","first-page":"273","article-title":"N-oleoyl-D-erythro-sphingosine-based analysis of ceramide by high performance liquid chromatography and its application to determination in diverse biological samples","volume":"3","author":"Lee","year":"2007","journal-title":"Mol. Cell. Toxicol."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/oxfordjournals.jbchem.a022492","article-title":"Preparation of fluorescence-labeled GM1 and sphingomyelin by the reverse hydrolysis reaction of sphingolipid ceramide N-deacylase as substrates for assay of sphingolipid-degrading enzymes and for detection of sphingolipid-binding proteins","volume":"126","author":"Nakagawa","year":"1999","journal-title":"J. Biochem."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/abio.2002.5579","article-title":"Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase","volume":"303","author":"Min","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB31|cit31","first-page":"4375","article-title":"Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine","volume":"59","author":"Sarkaria","year":"1999","journal-title":"Cancer Res."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/BF01923181","article-title":"Thermozymocidin new antifungal antibiotic from a thermophilic eumycete","volume":"28","author":"Craveri","year":"1972","journal-title":"Experientia"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7164\/antibiotics.47.208","article-title":"Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite","volume":"47","author":"Fujita","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2116\/analsci.25.855","article-title":"Determination of myriocin in natural and cultured Cordyceps cicadae using 9-fluorenylmethyl chloroformate derivatization and high-performance liquid chromatography with UV-detection","volume":"25","author":"Yu","year":"2009","journal-title":"Anal. Sci."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/j.1460-2075.1993.tb05633.x","article-title":"Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15","volume":"12","author":"McGowan","year":"1993","journal-title":"EMBO J."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(08)60785-X","article-title":"p53 and human cancer: the first ten thousand mutations","volume":"77","author":"Hainaut","year":"2000","journal-title":"Adv. Cancer Res."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1126\/science.282.5395.1893","article-title":"Linkage of ATM to cell cycle regulation by the Chk2 protein kinase","volume":"282","author":"Matsuoka","year":"1998","journal-title":"Science"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/351242a0","article-title":"Dephosphorylation and activation of a p34cdc2\/cyclin B complex in vitro by human CDC25 protein","volume":"351","author":"Strausfeld","year":"1991","journal-title":"Nature"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/auto.7.2.14074","article-title":"Caffeine induces apoptosis by enhancement of autophagy via PI3K\/Akt\/mTOR\/p70S6K inhibition","volume":"7","author":"Saiki","year":"2011","journal-title":"Autophagy"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1074\/jbc.M610104200","article-title":"Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells","volume":"282","author":"Gabrielli","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1742-7843.2008.00231.x","article-title":"Caffeine inhibits the proliferation of liver cancer cells and activates the MEK\/ERK\/EGFR signalling pathway","volume":"102","author":"Okano","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00018-005-5543-z","article-title":"The clinical potential of sphingolipid-based therapeutics","volume":"63","author":"Fox","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/pros.21285","article-title":"HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1\/2 and S1P receptors, and promote cell migration and invasion","volume":"71","author":"Sekine","year":"2011","journal-title":"Prostate"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB44|cit44","first-page":"537","article-title":"Effect of ceramide on apoptosis of human colon cancer HT-29 cells","volume":"35","author":"Zhang","year":"2006","journal-title":"Wei Sheng Yan Jiu"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB45|cit45","first-page":"263","article-title":"Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells","volume":"29","author":"Sala","year":"2003","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"12960","DOI":"10.1074\/jbc.M110699200","article-title":"Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide","volume":"277","author":"Ogretmen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2003.08.034","article-title":"Ceramide synthesis and metabolism as a target for cancer therapy","volume":"206","author":"Reynolds","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/ijc.22886","article-title":"Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer","volume":"121","author":"Devalapally","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/sj.onc.1205037","article-title":"P53 mediates ceramide-induced apoptosis in SKN-SH cells","volume":"21","author":"Kim","year":"2002","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB50|cit50","first-page":"21","article-title":"Inhibition of p53 sensitizes MCF-7 cells to ceramide treatment","volume":"37","author":"Struckhoff","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.2741\/1755","article-title":"The RAS\/RAF\/MEK\/ERK and PI3K\/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma","volume":"10","author":"Meier","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1042\/CS20090452","article-title":"Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition","volume":"118","author":"Glaros","year":"2010","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1042\/BJ20081149","article-title":"Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells","volume":"417","author":"Watson","year":"2009","journal-title":"Biochem. J."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jcp.21969","article-title":"Ceramide plays a prominent role in MDA-7\/IL-24-induced cancer-specific apoptosis","volume":"222","author":"Sauane","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1111\/j.1365-2184.2011.00761.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"27213","DOI":"10.1074\/jbc.M109.087791","article-title":"Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains","volume":"285","author":"Ohkawa","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["Cell Proliferation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2184.2011.00761.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2184.2011.00761.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T10:07:01Z","timestamp":1712484421000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2184.2011.00761.x"}},"subtitle":["Myriocin inhibits B16F10 melanoma cell growth"],"short-title":[],"issued":{"date-parts":[[2011,6,6]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2184.2011.00761.x","relation":{},"ISSN":["0960-7722"],"issn-type":[{"value":"0960-7722","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,6]]}}}